| LVEDV at rest (ml) | LVESV at rest (ml) | LVEF at rest (%) | Type stressors | Dose (mcg) | LV Contractile reserve criteria |
---|---|---|---|---|---|---|
Da Costa A [8] | 249 ± 92 | 187 ± 75 | 26 ± 5 | dobutamine | 10 | EF increase >1.25-fold |
Rocchi G [9] | 183 ± 54 | 139 ± 45 | 24 ± 5 | exercise | - | WMSI decrease >0.25 |
Ciampi Q [10] | 176 ± 64 | 129 ± 52 | 27 ± 6 | dobutamine | 40 | WMSI decrease >0.20 |
Lancellotti P [11] | 184 ± 39 | 134 ± 32 | 27 ± 5 | exercise | - | EF increase >6.5% |
Senechal M [12] | 216 ± 65 | 180 ± 62 | 19 ± 7 | dobutamine | 20 | WMSI decrease >0.25 |
Chaundry FA [13] | 108 ± 32 | 87 ± 23 | 18 ± 7 | dobutamine | 20 | WMSI decrease >0.31 |
Altman RK [14] | - | 116 ± 40 | 28 ± 6 | dobutamine | 10 | EF increase >20% |
Gasparini M [15] | 215 ± 79 | 159 ± 65 | 27 ± 6 | dobutamine | 20 | EF increase >5 points |
Pugliese M [16] | - | - | 27 ± 4 | dobutamine | 20 | WMSI decrease >0.20 |
Mizia-Stec K [17] | - | - | 24 ± 6 | dobutamine | 20 | WMSI decrease >0.20 |
Murin P [18] | 227 ± 66 | 168 ± 55 | 26 ± 7 | dobutamine | 40 | EF increase >7% |
Mean Value | 195 ± 61 | 144 ± 49 | 25 ± 6 |  | 22 |  |